Provectus Biopharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2024
Total Assets: $1.0M
Liabilities Breakdown FY2024
Total Liabilities: $7.0M
Asset Breakdown
Total Assets: $1.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $307.4K | 30.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.9K | 0.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $694.0K | 69.0% |
Liabilities Breakdown
Total Liabilities: $7.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.1M | 15.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $5.9M | 84.1% |